Cholesterol lowering in patients with CHD and metabolic syndrome.
Goldstein
Mark R
MR
D000069059:Atorvastatin; D003327:Coronary Disease / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications / Q000401:mortality; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin